EPO Biomarkers Market Size & Growth Analysis Report, 2021-2027

The global EPO Biomarkers market is anticipated to grow at a modest CAGR of around 5.3% during the forecast period (2021-2027). EPO is produced by the kidneys and is a factor responsible for regulating red blood cell (RBC) production in mammals. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Among these, the erythropoietin alfa is used to treat anemia and cancer cells and it increases the count of red blood cells in the body. Moreover, the erythropoietin biomarkers are used to treat end-stage renal diseases (ESRD), and anemia induced from multiple myeloma, cancer, and AIDS-associated anemia. 

 To Request a Sample of our Report on EPO Biomarkers Market:  https://www.omrglobal.com/request-sample/epo-biomarkers-market

The rising prevalence of chronic kidney disease (CKD) is the major factor driving the EPO Biomarkers demands in various end-users. According to the CDC estimates for 2021, the number of American adults who have chronic kidney disease (CKD) is now estimated to be 37 million, which is 15% of the total population. Several factors including an aging population and increased prevalence of risk factors such as diabetes and hypertension are the major cause of CKDs according to CDC. The reason behind the prevalence of chronic kidney diseases is that the people who have CKDs are not aware of it. One of every two people with very low kidney function, and who are not on dialysis, don’t know they have CKD. The National Kidney Foundation (NKF) estimates that one of every three adults – some 80 million people – is at risk for CKD. 

Moreover, the approvals of the drugs produced by major players also enhancing the market growth. For instance, in June 2020, Kyowa Kirin Co., Ltd., announced that Duvroq, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), from GSK, had been approved in Japan by the Ministry of Health, Labour and Welfare. The drug found its use for the treatment of patients with renal anemia due to CKD. Besides, in Sept 2019, the INVOKANA (Canagliflozin) drug produced by the Janssen Pharmaceutical Companies of Johnson & Johnson got the approval from US FDA. The drug is used to reduce the risk of end-stage kidney disease (ESKD) and cardiovascular events in patients with Type 2 diabetes and CKD. Thus, the approvals will help manufacturers to increase their production to fulfil the market demands, which will further expected to boost the market growth.

 Market Coverage

·                  The market number available for – 2020-2027

·                  Base year- 2020

·                  Forecast period- 2021-2027

Segment Covered- 

·                  By Biomarker Type

·                  By Applications

·                  By End-User

Regions Covered-

·                  North America

·                  Europe

·                  Asia-Pacific

·                  Rest of the World

·                  Competitive Landscape-   Amgen Inc, BioAgilytix Labs, Novartis AG, Pfizer Inc., Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Agilent Technologies, Inc, among others.

(Get 15% Discount on Buying this Report)

A full Report of EPO Biomarkers Market is Available at:  https://www.omrglobal.com/industry-reports/epo-biomarkers-market

Key questions addressed by the report

·                  What is the market growth rate?

·                  Which segment and region dominate the market in the base year?

·                  Which segment and region will project the fastest growth in the market?

·                  How COVID-19 impacted the market?

Ø  Deviation from the pre-COVID-19 forecast

Ø  Most affected region and segment

·        Who is the leader in the market?

·        How players are addressing challenges to sustain growth?

·        Where is the investment opportunity?

Global EPO Biomarkers Market Report Segment

By Biomarker Type

·                  Erythropoietin Alfa

·                  Erythropoietin Beta

·                  Erythropoietin Zeta

·                  Erythropoietin Theta

·                  Recombinant Human Erythropoietin

·                  Darbepoietin Alfa

By Applications

·                  End-Stage Renal Disorder

·                  Cancers

·                  Rheumatoid Arthritis

·                  AIDS

·                  Neurology

·                  Hematology

·                  Others (Anaemia of Chronic Inflammatory Syndromes)

By End Users

·                  Diagnostic Centres

·                  Ambulatory Care and Surgical Centres

·                  Hospitals

Global EPO Biomarkers Market Report Segment by Region

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan

·                  South Korea

·                  Rest of APAC

Rest of The World

·                  Latin America 

·                  Middle East & Africa

Company Profiles 

·        Agilent Technologies, Inc.

·        Amgen Inc.

·        BioAgilytix Labs

·        Bio-Rad Laboratories, Inc.

·        F. Hoffmann-La Roche Ltd.

·        GenScriptBiotech Corp.

·        Johnson & Johnson Services, Inc.

·        Kyowa Kirin Co., Ltd.

·        MerckKGaA

·        Myriad RBM

·        Meso Scale Diagnostics, LLC

·        Novartis International AG

·        Nexelis

·        Thermo Fisher Scientific Inc.

Reasons to Buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/epo-biomarkers-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more